TRANSCODE THERAPEUTICS INC (RNAZ)

US89357L3033 - Common Stock

3.43  -0.18 (-4.99%)

After market: 3.43 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
ASSETS
Current Assets
Cash
N/AN/A9.00KN/AN/A
Cash Equivalents
4.91M2.77M4.97M20.83M828.00K
Receivables
N/AN/A360.00KN/AN/A
Other Current Assets
1.80M1.69M2.04M1.91M3.00K
Total Current Assets
6.71M4.46M7.38M22.73M831.00K
 
Non-Current Assets
PPE Net
465.00K602.00K209.00K206.00KN/A
Other Non-Current Assets
112.00K112.00KN/A0.00224.00K
Total Non-Current Assets
576.00K715.00K209.00K206.00K224.00K
 
TOTAL ASSETS
7.29M5.17M7.59M22.94M1.05M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
1.52M1.51M923.00KN/AN/A
Accounts Payable
1.19M1.96M3.42M2.50M369.00K
Other Current Liabilities
0.0027.00K0.0031.00K36.00K
Total Current Liabilities
2.71M3.49M4.35M2.53M405.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.002.09M
Other Non-Current Liabilities
0.0038.00KN/A0.001.97M
Total Non-Current Liabilities
0.0038.00K0.000.004.06M
 
TOTAL LIABILITIES
2.71M3.53M4.35M2.53M4.46M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-49.74M-46.42M-27.87M-10.30M-3.46M
Additional Paid In Capital
54.33M48.06M31.11M30.71M53.00K
Common Shares
1.00K0.001.00K1.00K0.00
Shares Outstanding
5.81M627.00K16.00K16.00K11.00K
Tangible Book Value per Share
0.792.62202.561.28K-309.82
Total Shareholders' Equity
4.58M1.64M3.24M20.40M-3.41M
 
TOTAL LIABILITIES AND EQUITY
7.29M5.17M7.59M22.94M1.05M
 
Statistics
Debt/Equity
N/AN/AN/AN/A-0.61
Current Ratio
2.481.281.708.972.05
Return On Assets (ROA)
-233.96%-358.73%-231.48%-29.83%-222.17%
Return On Equity (ROE)
-372.08%-1130.17%-541.96%-33.54%N/A

All data in USD , ROIC based on taxRate of 0.21

Charts